Search company, investor...

Blue Blood Biotech

About Blue Blood Biotech

Blue Blood Biotech develops plasma-derived and recombinant protein platforms and diagnostic reagents. Through these platform technologies, it delivers life-saving medicine.

Headquarters Location

2F., No.57, DongXing Rd. Xinyi District

Taipei, 11070,


Missing: Blue Blood Biotech's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Blue Blood Biotech's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Blue Blood Biotech

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Blue Blood Biotech is included in 1 Expert Collection, including Diabetes.



1,903 items

Blue Blood Biotech Patents

Blue Blood Biotech has filed 1 patent.

The 3 most popular patent topics include:

  • Clusters of differentiation
  • Cytokines
  • Rare diseases
patents chart

Application Date

Grant Date


Related Topics




Application Date


Grant Date


Related Topics



Latest Blue Blood Biotech News

8th Annual Biologics World Taiwan 2020: 3-Day Event (Taipei City, Taiwan – September 1-3, 2020) –

Jul 30, 2020

While China, India, and Korea are leading the pack in the Asian region for biologics, Taiwan has also been stepping up its efforts to boost its biologics sector and capture a share of the global market. In 2009, the Taiwan Biotechnology Takeoff Diamond Action Plan was launched by the government, with the aim of strengthening the country’s translational research and commercialisation skills, establishing a biotechnology venture capital fund, founding a Food and Drug Administration, and creating an integrated biotech incubation center. Two biotechnology clusters have already been built in Taiwan, with the Southern Taiwan Science Park hosting nearly 20 biopharmaceutical companies, and the Hsinchu Biomedical Science Park expected to accommodate 30 biopharmaceutical manufacturers. The government also plans to create an integrated incubation center, to be developed in a third park and called the National Biotechnology Development Park, which will also contain animal testing, R&D service, and legal information centers. Biologics World Taiwan provides the FIRST and ONLY platform for senior decision-makers who will influence the future of Taiwan’s biologics industry. Taiwanese and international biopharmas, biotechs, CMOs, CROs, and solution providers will convene to discuss strategic issues, leverage partnerships, share best practices, and capitalize on the potential of Taiwan’s growing biologics industry. Sources / Contributors Jason Huang, Chief Medical Officer, BRIM Biotech, Taiwan Shuichi Yamamoto, Director, Biomedical Engineering Center (YUBEC) & Professor Bio-Process Engineering Laboratory, Yamaguchi University, Japan Ko-Chung Lin, CEO & Founder, PharmaEssentia, Taiwan Juine-Ruey Chen, Vaccine R&D Director, RH Biopharma, Taiwan Mahalia Corrales, Senior Director of Process Development, JHL Biotech, Taiwan Lee Cheng Liu, President & CEO, Eirgenix, Taiwan Pauline Y. Lau, CEO, Suntec Medical, Taiwan Julio Lin, Vice President, Blue Blood Biotech Corp, Taiwan Dr. Leah Lo, CEO, Orient Pharma, Taiwan Dr. Ye-Su Chao, Vice President, GNTbm, Taiwan Dr. Allen Chao, CEO, Tanvex, Taiwan Alvan Chou, R&D Director, Mycenax Biotech, Taiwan Yuan-Hua Ding, Vice President and Head, Asia Discovery Labs Emerging Science & Innovation (ES&I), Pfizer Worldwide Research, Development and Medical, China John (Tsu-An) Hsu, Investigator, Division Biotechnology and Pharmaceutical Research, National Health Research Institutes, Taiwan Dr. Frieda Chou, Director – Quality Management, United Biopharma, Taiwan Tzu Hung Lin, Research Scientist, Industrial Technology Research Institute (ITRI), Taiwan Wan-Jiun Chen, Deputy Director, Cancer Stem Cells Therapeutics Department, Oneness Biotech, Taiwan Hsiu-Ling Hsiao, Chief Scientific Officer, Ever Supreme, Taiwan Eric Thang, Chairman/CEO, Lukas Biomedical Inc, Taiwan Shih-Hwa Chiou, Professor, National Yang-Ming University, Taiwan Stanley Chang, CEO/Chairman, Medigen Biotechnology Corp, Taiwan Rita Yen-Hua Huang, CEO/Director, TMU Research Center for Cell Therapy & Regeneration Medicine, Taiwan Chun-Che Yen, Deputy General Manager, Kartigen Biomedical Taiwan Wan-Jiun Chen, Deputy Director, Cancer Stem Cells Therapeutics Department, Oneness Biotech Taiwan Dar-Jen Hsieh, CEO, ACRO Biomedical Co. Ltd, Taiwan Prof Liu Hua Chang, Professor Emeritus of Orthopaedic Surgery, National Taiwan University, Taiwan Dr Po Cheng Lin, General Manager, GWOXI, Taiwan Hun-Chi Lin, CEO, Li Bo Pharma Corp, Taiwan Jan Mou Lee, Founder, Fullhope Biomedical, Taiwan Dr William Hung, Physician, Maria Von, Taiwan Yi Pei Hung, General Manager, Yupro Biomedical Services, Taiwan For more information about this conference visit Contacts

Blue Blood Biotech Frequently Asked Questions (FAQ)

  • Where is Blue Blood Biotech's headquarters?

    Blue Blood Biotech's headquarters is located at 2F., No.57, DongXing Rd., Taipei.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.